M. Douglas Anglin, Ph.D.

ISAP Researchers' Profiles

M. Douglas Anglin, Ph.D.

M. Douglas Anglin (Ph.D.; Social Psychology, UCLA, 1980) was the Founding Director of the UCLA Drug Abuse Research Center (1984-1997) and was an Associate Director of the Integrated Substance Abuse Programs (ISAP) from 1998 to 2010. He is currently a Senior Advisor in the Department of Psychiatry and Biobehavioral Sciences. Dr. Anglin has been conducting research on substance abuse epidemiology, etiology, treatment evaluation, and social policy since 1972. He has been Principal Investigator on more than 25 federally funded research studies and on numerous state- and foundation-supported projects. He has been the author or co-author of more than 260 published articles. Dr. Anglin has served as an advisor to many national treatment evaluation studies, including the Drug Abuse Treatment Outcome Study and the Federal Bureau of Prisons Drug Programs Evaluation Project. He has also served as consultant to the following agencies: National Institute on Drug Abuse, Office of National Drug Control Policy, Center for Substance Abuse Treatment, National Academy of Sciences Institute of Medicine, National Institute of Justice, California Youth Authority and Departments of Alcohol and Drug Programs and Corrections, and Los Angeles County Alcohol and Drug Program Administration.

Education and Training

  • University of Arkansas, Fayetteville, B.A., Chemistry, 1969
  • University of California, Los Angeles, M.A., Psychology, 1970
  • University of California, Los Angeles, Ph. D., Social Psychology, 1980

Specialties

  • Drug Abuse: Etiology, Epidemiology, Treatment, Treatment Evaluation, Substance Abusing Offenders, Research Methodology, Social Policy

Contact Info

UCLA Integrated Substance Abuse Programs
11075 Santa Monica Blvd., Suite 100
Los Angeles, CA 90025
doug_anglin@hotmail.com

Selected Publications

(Publications selected from more than 260 publications)

  • Hser, Y.-I., Anglin, M.D., Grella, C.E., Longshore, D., & Prendergast, M L. (1997).  Drug treatment careers: A conceptual framework and existing research findings. Journal of Substance Abuse Treatment, (14)6, 543-558.
  • Farabee, D., Prendergast, M.L., & Anglin, M.D. (1998) The effectiveness of coerced treatment for drug-abusing offenders. Federal Probation, 62, 3-10.
  • Kasarabada, N. D., Anglin, M. D., Khalsa-Denison, E., & Paredes, A. (1998). Variations in psychosocial functioning associated with patterns of progression in cocaine-dependent men. Addictive Behaviors, 23(2), 179-189.   
  • Longshore, D., Annon, J., & Anglin, M.D. (1998).  HIV Prevalence among injection drug users in three Northern California communities.  Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 19, 200.
  • Longshore, D., Turner, S., & Anglin, M.D. (1998).  Effects of case management on drug users’ risky sex.  The Prison Journal, 78, 6-30.
  • Polinsky, M. L., Hser, Y., Anglin, M. D., & Maglione, M. A. (1998). Drug-user treatment programs in a large metropolitan area. Substance Use and Misuse, 33(8), 1739-1761.
  • Anglin, M. D., & Perrochet, B. (1998). Drug use and crime: A historical review of research conducted by the UCLA Drug Abuse Research Center. Substance Use and Misuse, 33(9), 1871-1914.
  • Hser, Y., Chou, C.P., Hoffman, V., & Anglin, M.D. (1999). Cocaine use and high-risk sexual behavior among STD clinic patients. Sexually Transmitted Diseases, 26(2), 82-86.
  • Farabee, D., Prendergast, M., Cartier, J., Wexler, H., Knight, K., & Anglin, M.D. (1999) Barriers to implementing effective correctional drug treatment programs. Prison Journal, 79(2), 150-162.
  • Grella, C. E., Hser, Y.I., Joshi, V., & Anglin, M. D. (1999). Patient histories, retention, and outcome models for younger and older adults in DATOS. Drug and Alcohol Dependence, 57(2), 151-166. 
  • Maglione, M.A., Chao, B., & Anglin, M.D. (2000). Residential treatment of methamphetamine users: Correlates of drop-out from the California Alcohol and Drug Data System (CADDS), 1994-1997. Addiction Research, 8(1), 65-79.
  • Shaw, V. N., Hser. Y.I., Anglin, M. D., & Boyle, K. (1999). Sequences of powder cocaine and crack use among arrestees in Los Angeles County. American Journal of Drug and Alcohol Abuse, 25(1), 47-66.
  • Simpson, D.D., Joe, G.W., Fletcher, B.W., Hubbard, R.L., & Anglin, M.D. (1999). A national evaluation of treatment outcomes for cocaine dependence.  Archives of General Psychiatry, 56, 507-514.
  • Simpson, D.D., Joe, G.W., Fletcher, B.W., Hubbard, R.L., & Anglin, M.D. (1999). A national evaluation of treatment outcomes for cocaine dependence.  Archives of General Psychiatry, 56, 507-514.
  • Anglin, M.D., & Rawson, R.A. (Eds.). (2000). The CSAT methamphetamine treatment project: Moving research into the "real world." Journal of Psychoactive Drugs, 32(2), 221-228.
  • Brecht, M.-L., von Mayrhauser, C.V., & Anglin, M.D. (2000). Predictors of relapse after treatment for methamphetamine use. Journal of Psychoactive Drugs, 32(2), 211-220.
  • Grella, C.E., Annon, J.J., & Anglin, M.D. (2000). Drug use and risk for HIV among women arrestees in California. AIDS and Behavior, 4(3), 289-295.
  • Grella, C.E., Etheridge, R., Joshi, V., & Anglin, M.D. (2000).  Delivery of HIV risk-reduction services in drug treatment programs.  Journal of Substance Abuse Treatment, 19(3), 229-237.
  • Farabee, D., Joshi, V., & Anglin, M.D. (2001). Addiction careers and criminal specialization. Crime & Delinquency, 47(2), 196-220.
  • Farabee, D., Shen, H., Hser Y., Grella, C.E., & Anglin, M.D. (2001). The effect of drug treatment on adolescent criminal behavior.  Journal of Adolescent Research. 16(6), 679-696.
  • Flynn, P.M., Simpson, D.D., Anglin, M.D., & Hubbard, R.L. (2001).  Comment on “nonresponse and selection bias in treatment follow-up studies.”  Substance Use and Misuse, 36(12), 1749-51, 1753-7.
  • Hser, Y., Grella, C.E., Hubbard, R.L., Hsieh, S.C., Fletcher, B.W., Brown, B.S., & Anglin, M.D. (2001).  An evaluation of drug treatments for adolescents in four U.S. cities. Archives of General Psychiatry, 58, 689-695.
  • Hser, Y., Shen, H., Chou, C.-P., Messer, S., & Anglin, M.D. (2001). Analytic approaches for assessing long-term treatment effects:  Examples of empirical applications and findings.  Evaluation Review, 25(2), 233-262.
  • Hser, Y., & Anglin, M. D. (2002). Book review [Review of the book Making research relevant and beyond. Bridging the gap between practice and research: Forging partnerships with community-based drug and alcohol treatment]. Contemporary Psychology: APA Review of Books, 47(1), 75-78.
  • Von Mayrhauser, C., Brecht, M.L., & Anglin, M.D. (2002).  Use ecology and drug use motivations of methamphetamine users admitted to substance treatment facilities in Los Angeles: An emerging profile.  Journal of Addictive Diseases, 21(1), 45-60.
  • Riehman, K.S., Iguchi, M.Y., & Anglin, M.D. (2002). Depressive symptoms among amphetamine and cocaine users before and after substance use treatment. Psychology of Addictive Behaviors, 16(4), 333-337. 
  • Grella, C.E., Joshi, V., & Anglin, M.D. (2003). Gender differences and treatment outcomes among methadone maintenance patients in DATOS.  Journal of Maintenance in the Addictions, 2(1/2), 103-128.
  • Hser, Y.-I., Huang, D., Chou, C.-P., Teruya, C., & Anglin, M D. (2003). Longitudinal patterns of treatment utilization and outcomes among methamphetamine abusers: A growth curve modeling approach. Journal of Drug Issues, 33, 921-938.
  • Rawson, R.A., Marinelli-Casey, P., Anglin, M.D., et al. (2004). A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction, 99, 708-717.
  • Hser, Y.-I., Huang, D., Teruya, C., & Anglin, M.D. (2004). Diversity of drug abuse treatment utilization patterns and outcomes. Evaluation and Program Planning, 27, 309-319.
  • Brecht, M.-L., O'Brien, A., Mayrhauser, C., & Anglin, M. D. (2004). Methamphetamine use behaviors and gender differences. Addictive Behaviors, 29, 89-106.
  • Hser, Y.-I., Huang, Y.-C., Teruya, C., & Anglin, M. D. (2004). Gender differences in treatment outcomes over a three-year period: A path model analysis. Journal of Drug Issues, 34, 419-440.
  • Brecht, M.-L., Anglin, M. D., & Dylan, M. (2005). Coerced treatment for methamphetamine abuse: Differential patient characteristics and outcomes. American Journal of Drug and Alcohol Abuse, 31, 337-356.
  • Brecht, M.L., Greenwell, L., & Anglin, M. D. (2005). Methamphetamine treatment: Trends and predictors of retention and completion in a large state treatment system (1992-2002). Journal of Substance Abuse Treatment, 29, 295-306.
  • Longshore, D., Annon, J., Anglin, M D., & Rawson, R.A. (2005). Levo-alpha-acetylmethadol (LAAM) versus methadone: Treatment retention and opiate use. Addiction, 100(8), 1131-1139.
  • Anglin, M.D. (2006). Conversation with M. Douglas Anglin. Addiction, 101(2), 169-180.
  • Brecht, M.-L., Greenwell, L., von Mayrhauser, C., & Anglin, M.D. (2006). Two-year outcomes of treatment for methamphetamine use. Journal of Psychoactive Drugs, SARC Suppl. 3, 415-426.
  • Hser, Y.-I., Stark, M.E., Paredes, A., Huang, D., Anglin, M.D., & Rawson, R. (2006). A 12-year follow-up of a treated cocaine-dependent sample. Journal of Substance Abuse Treatment, 30, 219-226.
  • Anglin, M.D., Conner, B.T., Annon, J., & Longshore, D. (2007). Levo-alpha-acetylmethadol (LAAM) versus methadone maintenance: 1-year treatment retention, outcomes and status. Addiction, 102(9), 1432-1442.
  • Anglin, M.D., Urada, D., Brecht, M.L., Hawken, A., Rawson, R., & Longshore, D. (2007).  Criminal justice treatment admissions for methamphetamine use in California: A focus on proposition 36.  Journal of Psychoactive Drugs, SARC Supplement No 4, 367-381.
  • Brecht, M.-L., Greenwell, L., & Anglin, M.D. (2007). Substance use pathways to methamphetamine use among treated users. Addictive Behaviors, 32(1), 24-38.
  • Hser, Y.-I., Evans, E., Teruya, C., Huang, D., & Anglin, M.D. (2007). Predictors of short-term treatment outcomes among Proposition 36 participants.  Evaluation and Program Planning, 30, 187-196. 
  • Hser, Y.-I., Huang, D., Chou, C.-P., & Anglin, M.D. (2007). Trajectories of heroin addiction: Growth mixture modeling results based on a 33-year follow-up study. Evaluation Review, 31(6), 548-563.
  • Hser, Y.-I., Longshore, D., & Anglin, M.D. (2007). The life course perspective on drug use: A conceptual framework for understanding drug use trajectories. Evaluation Review, 31(6), 515-547.
  • Hser, Y.-I., Teruya, C., Brown, A.H., Huang, D., Evans, E., & Anglin, M.D. (2007). Impact of California’s Proposition 36 on the drug treatment system: Treatment capacity and displacement. American Journal of Public Health, 97(1), 104-109.
  • Campos, M.D., Podus, D., Anglin, M.D., & Warda, U. (2008). Mental health need and substance abuse problem risk: Acculturation among Latinas as a protective factor among CalWORKs applicants and recipients. Journal of Ethnicity in Substance Abuse, 7(3), 268-291. PMID: 19042810
  • Maly, R.C., Stein, J.A., Umezawa, Y., Leake, B., & Anglin, M.D. (2008). Racial/ethnic differences in breast cancer outcomes among older patients: Effects of physician communication and patient empowerment. Health Psychology, 27(6), 728-736.
  • Anglin, M.D., Brown, B.S., Dembo, R., & Leukefeld, C. (2009). Criminality and addiction: Selected issues for future policies, practice, & research. Journal of Drug Issues, 39(1), 89-100.
  • Anglin, M.D., Conner, B.T., Annon, J.J., & Longshore, D. (2009). Longitudinal effects of LAAM and methadone maintenance on heroin addict behavior. Journal of Behavioral Health Services and Research, 36(2), 267-282. PMID: 19023658
  • Conner, B.T., Anglin, M.D., Annon, J., & Longshore, D. (2009). Effect of religiosity and spirituality on drug treatment outcomes. Journal of Behavioral Health Services and Research, 36(2), 189-198. PMID: 18770043
  • Conner, B.T., Longshore, D., & Anglin, M.D. (2009). Modeling attitude towards drug treatment: The role of internal motivation, external pressure, and dramatic relief. Journal of Health Services and Research, 36(2), 150-158. DOI: 10.1007/s11414-008-9119-1
  • Grella, C.E., & Anglin, M.D. (2009). Dedication of special issue of JBHS&R in memory of Douglas Longshore. Journal of Behavioral Health Services and Research, 36(2), 129-130. DOI: 10.1007/s11414-008-9156-9
  • Grella, C.E., & Anglin, M.D. (2009). Introduction to the special issue on addiction health services: In memory of Douglas Longshore. Journal of Behavioral Health Services & Research, 36(2), 131-136. PMID: 19082737
  • Hellemann, G., Conner, B.T., Anglin, M.D., & Longshore, D. (2009). Seeing the trees despite the forest: Applying recursive partitioning to the evaluation of drug treatment retention. Journal of Substance Abuse Treatment, 36, 59-64. PMID: 18599252
  • Longshore, D., Anglin, M.D., & Conner, B.T. (2009). Are religiosity and spirituality useful constructs in drug treatment research? Journal of Behavioral Health Services and Research, 36(2), 177-188. PMID: 19023659
  • Ober, A.J., Iguchi, M.Y., Weiss, R.E., Gorbach, P.M., Heimer, R., Ouellet, L.J., Shoptaw, S., Anglin, M.D., & Zule, W.A. (2010). The relative role of perceived partner risks in promoting condom use in a three-city sample of high-risk, low-income women. AIDS and Behavior, Oct 26. [Epub ahead of print] PMID: 20976538
  • Evans, E., Li, L., Urada, D., & Anglin, M.D. (2010). Comparative effectiveness of California’s Proposition 36 and drug court programs before and after propensity score matching. Crime & Delinquency. Published online Oct. 1.
  • Evans, E., Anglin, M.D., Urada, D., & Yang, J. (2011). Promising practices for delivery of court-supervised substance abuse treatment: Perspectives from six high-performing California counties operating Proposition 36. Evaluation and Program Planning, 34(2), 124-134. PMID: 20965568

Anglin publications from 2012-2014

  • Gonzales, R., Anglin, M.D., Beattie, R., Ong, C.A., & Glik, D.C. (2012). Perceptions of chronicity and recovery among youth in treatment for substance use problems. Journal of Adolescent Health, 51(2), 144-149. DOI: http://dx.doi.org/10.1016/j.jadohealth.2011.11.010
  • Gonzales, R., Anglin, M.D., Beattie, R., Ong, C.A., & Glik, D.C. (2012). Understanding recovery barriers: Youth perceptions about substance use relapse. American Journal of Health Behavior, 36(5), 602-614. PMCID: PMC4023909. doi: 10.5993/AJHB.36.5.3.
  • Nosyk, B., Sun, H., Evans, E., Marsh, D.C., Anglin, M.D., Hser, Y.I., & Anis, A.H. (2012). Defining dosing pattern characteristics of successful tapers following methadone maintenance treatment: Results from a population-based retrospective cohort study. Addiction, 107, 1621-1629. PMCID: PMC3376663 doi: 10.1111/j.1360-0443.2012.03870.x
  • Anglin, D.M., Jaffee, A., Nysok, B., Urada, D., & Evans, E. (2013). Offender diversion into substance use disorder treatment: Demographic variation in the economic impact of California’s Proposition 36. Journal of Alcoholism and Drug Dependence, 1:140. doi: 10.4172/2329-6488.1000140
  • Anglin, M.D., Nosyk, B., Jaffe, A., Urada, D., & Evans, E. (2013). Offender diversion into substance use disorder treatment: The economic impact of California's Proposition 36. American Journal of Public Health, 103(6), 1096-1102. PMCID: PMC3698729
  • Gonzales, R., Anglin, M.D., Glik, D.C., & Zavalza, C. (2013). Perceptions about recovery needs and drug-avoidance recovery behaviors among youth in substance abuse treatment. Journal of Psychoactive Drugs, 45(4), 297-303. PMCID: PMC4018414
  • Huang, D.Y., Lanza, H.I., & Anglin, M.D. (2013). Association between adolescent substance use and obesity in young adulthood: A group-based dual trajectory analysis. Addictive Behaviors, 38(11), 2653-2660. PMCID: PMC3777808
  • Huang, D.Y., Lanza, H.I., Wright-Volel, K., & Anglin, M.D. (2013). Developmental trajectories of childhood obesity and risk behaviors in adolescence. Journal of Adolescence, 36(1), 139-148. PMCID: PMC3530618
  • Nosyk, B., Anglin, M.D., Brecht, M.L., Lima, V.D., & Hser, Y.I. (2013). Characterizing durations of heroin abstinence in the California Civil Addict Program: Results from a 33-year observational cohort study. American Journal of Epidemiology, 177(7), 675-682. PMCID: PMC3657532
  • Nosyk, B., Anglin, M.D., Brissette, S., Kerr, T., Marsh, D.C., Schackman, B.R., Wood, E., & Montaner, J.S. (2013). A call for evidence-based medical treatment of opioid dependence in the United States and Canada. Health Affairs, 32(8),1462-1469.
  • Evans, E., Li, L., Urada, D., & Anglin, M.D. (2014). Comparative effectiveness of California’s Proposition 36 and drug court programs before and after propensity score matching. Crime & Delinquency, 60(6), 909-938. doi:10.1177/0011128710382342
  • Gonzales, R., Ang, A., Murphy, D.A., Glik, D.C., & Anglin, M.D. (2014). Substance use recovery outcomes among a cohort of youth participating in a mobile-based texting aftercare pilot program. Journal of Substance Abuse Treatment, 47(1), 20-26. doi: 10.1016/j.jsat.2014.01.010. PMCID: PMC4011993 (Available July 1, 2015)
  • Gonzales, R., Anglin, M.D., & Glik, D.C. (2014). Exploring the feasibility of text messaging to support substance abuse recovery among youth in treatment. Health Education Research, 29(1), 13-22. PMCID: PMC3894666 (Available Feb. 1, 2015)
  • Evans, E., Li, L., Urada, D., & Anglin, M.D. (2014). Comparative effectiveness of California's Proposition 36 and drug court programs before and after propensity score matching. Crime and Delinquency, 60(6), 909-938. PMCID: PMC4203433 (Available Sept. 1, 2015) doi: 10.1177/0011128710382342
  • Huang, D.Y., Lanza, H.I., & Anglin, M.D. (2014). Trajectory of adolescent obesity: Exploring the impact of prenatal to childhood experiences. Journal of Child and Family Studies, 23(6), 1090-1101. PMCID: PMC4201654 (Available Aug. 1, 2015) doi: 10.1007/s10826-013-9766-6

Last updated - 01/22/2015

Click here to view other profiles.

Top of Page
2016 ISAP Publications
2015 ISAP Publications